You can buy or sell PGNX and other stocks, options, ETFs, and crypto commission-free!
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. Read More The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Expected Mar 12, Pre-Market